Discover how circulating cell-free DNA (cfDNA) is transforming the diagnosis and monitoring of metabolic diseases like ...

Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

Emergen Research Logo The increasing prevalence of liver diseases worldwide is a major growth driver in the liver disease therapeutics mark ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by ...

"A higher FT3/FT4 ratio was associated with an increased risk of developing NAFLD (OR 1.45) and greater severity of liver fibrosis (ORs 3.21–10.80), highlighting the potential role of thyroid hormones ...

Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...

The deadly non-alcoholic fatty liver disease is reaching epidemic proportions in India with 3 out of 10 adults and children ...

Dr. Meghraj Ingle reminds nonalcoholic fatty liver disease (NAFLD), which got no noticeable symptoms in its early stages, can ...